Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2022, Vol. 27 ›› Issue (6): 672-679.doi: 10.12092/j.issn.1009-2501.2022.06.011

Previous Articles     Next Articles

Roles of indoxyl sulfate in complications of chronic kidney disease

ZHU Xinru1,2, HUANG Xin1,2,3   

  1. 1New Drug Screening Center, Institute of Pharmaceutical Sciences, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; 2Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, Nanjing 210009, Jiangsu, China; 3Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing 210009, Jiangsu, China
  • Received:2022-04-14 Revised:2022-05-20 Online:2022-06-26 Published:2022-07-08

Abstract: Chronic kidney disease is a global public health problem, and its occurrence and development are closely related to the exposure of uremic toxins in vivo. Indoxyl sulfate is one of protein-bound enterogenous uremic toxin, it significantly accumulates in patients with chronic kidney disease as renal function declines. Indoxyl sulfate not only promotes the progression of chronic kidney disease, but also induces pathological changes in other tissues and organs, causing complications in other organs related to chronic kidney disease. This article mainly reviews the effect of indoxyl sulfate on blood vessels, muscle, skeleton and brain and their mechanisms, and summarizes chronic kidney disease treatment by clearing indoxyl sulfate.

Key words: chronic kidney disease, uremic toxin, complications of chronic kidney disease, indoxyl sulfate

CLC Number: